Global Coronary Heart Disease Diagnostic Imaging Devices Market Size study, By Modality (Computed Tomography, X rays, Ultrasound, Magnetic Resonance Imaging, Nuclear Medicine), and Regional Forecasts 2022-2028

Global Coronary Heart Disease Diagnostic Imaging Devices Market Size study, By Modality (Computed Tomography, X rays, Ultrasound, Magnetic Resonance Imaging, Nuclear Medicine), and Regional Forecasts 2022-2028

Global Coronary Heart Disease Diagnostic Imaging Devices Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Coronary Heart Disease Diagnostic Imaging Devices refer to medical Equipment which have application in diagnosis and monitoring of heart diseases such as leak in heart valves and defects in the size and shape of the heart. These devices are utilized by healthcare professionals to monitor functioning of Heart & its valves. Growing incidences of cardiovascular diseases and increasing demand for non-invasive diagnostic techniques as well as recent product launches from leading market players are driving the growth of Coronary Heart Disease Diagnostic Imaging Devices Market. For instance, as per World Health Organization – in 2019, around17.9 million people died from cardiovascular diseases, accounting for 32% of all global deaths. Furthermore, as per – European Society of Cardiology- in 2019, around 49 million people were diagnosed with cardiovascular disease in the EU, and CVDs cost around USD 218.09 billion a year in healthcare costs. Moreover, in July 2021, Abbott launched new insertable cardiac monitor (ICM), named Jot Dx, in the US. This new device is intended for diagnosis of abnormal heart rhythms. This device can be connected through Bluetooth to a mobile app called, myMerlin. This app can send data to doctors and patients in real time. Also, growing geriatric population and rising healthcare sector in emerging regions are anticipated to act as a catalyzing factor for the market demand during the forecast period. However, insufficient reimbursement scenario, dearth of skilled professionals and high cost of medical imaging systems impede the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Coronary Heart Disease Diagnostic Imaging Devices Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to presence of leading market players and growing prevalence of obesity in the region. Whereas, Asia Pacific is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as rising government investment in healthcare sector and rising incidences of cardiovascular diseases, would create lucrative growth prospects for the Coronary Heart Disease Diagnostic Imaging Devices Market across the Asia Pacific region.

Major market players included in this report are:
GE Healthcare
Fujifilm Corporation
Siemens Healthcare
Toshiba International Corporation
Hitachi Ltd.
Koninklijke Phillips
Canon Medical Systems Corporation
Analogic Corp
Epsilon Imaging
Lantheus Holdings

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Modality
Computed Tomography
X rays
Ultrasound
Magnetic Resonance Imaging
Nuclear Medicine
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Coronary Heart Disease Diagnostic Imaging Devices Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

GE Healthcare
Fujifilm Corporation
Siemens Healthcare
Toshiba International Corporation
Hitachi Ltd.
Koninklijke Phillips
Canon Medical Systems Corporation
Analogic Corp
Epsilon Imaging
Lantheus Holdings

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.